1428P Clinical benefit of combination chemo-immunotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic NSCLC
| Autor: | Landre, T., Sadaoui, N., Bouharati, D., Taleb, C. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S813-S814 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|